Companies: 10,795·Total market cap: $144.5T
Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.

TCRTNASDAQHealthcare● Active
$2.03
$-0.25(-10.96%)
Market Cap$4957556
P/E Ratio
52W High$6.2
52W Low$1.67

Alaunos Therapeutics, Inc.(TCRT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · TCRT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.01M$0.01M$0.01M$2.92M$0.40M
Cost of Revenue$0.00M$0.00M$4.80M$0.00M$0.00M
Gross Profit$0.01M$0.01M($4.80M)$2.92M$0.40M
Gross Margin %(computed)100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$1.36M$0.36M$16.28M$25.02M$49.64M
G&A Expenses$2.87M$4.46M$12.22M$13.14M$27.56M
Total Operating Expenses$4.23M$4.82M$29.47M$38.03M$77.95M
Operating Income($4.22M)($4.81M)($34.27M)($35.10M)($77.55M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$1.92M$3.15M$1.19M
Income Before Tax($4.18M)($4.68M)($35.14M)($37.73M)($78.75M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($4.18M)($4.68M)($35.14M)($37.73M)($78.75M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.20$-2.92$-21.97$-25.97$-53.80
Wtd Avg Shares1.95M1.60M1.60M1.45M1.43M
EBITDA($4.22M)($4.68M)($30.90M)($31.82M)($74.97M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Alaunos Therapeutics, Inc.

关于Alaunos Therapeutics, Inc.(TCRT)损益表

Alaunos Therapeutics, Inc.(TCRT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,TCRT实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.00B)(净利率-83520.00%)。

常见问题

TCRT · 4 问

Alaunos Therapeutics, Inc.(TCRT)2025财年营收为$0.00B,同比down50.0%。

TCRT revenueTCRT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08